Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-22

Clinical Trial Update: Amitriptyline in Treating Hypoglycemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating amitriptyline for hypoglycemia in individuals with type 1 diabetes and hypoglycemia unawareness was terminated with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amitriptyline (amitriptyline)

Snippet

Sponsor: University of Utah | Conditions: Type1 Diabetes Mellitus, Hypoglycemia Unawareness | Phase 2 | Status: TERMINATED | Results posted: 2019-07-22